Nuvation Bio Stock Analysis

Nuvation Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nuvation Bio recorded a loss per share of 0.35. The entity had not issued any dividends in recent years. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York. Nuvation Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 85 people. To find out more about Nuvation Bio contact David Hung at 332 208 6102 or learn more at https://www.nuvationbio.com.

Nuvation Bio Investment Alerts

Nuvation Bio Upcoming and Recent Events

Nuvation Largest EPS Surprises

View All Earnings Estimates

Nuvation Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 661.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nuvation Bio's market, we take the total number of its shares issued and multiply it by Nuvation Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Nuvation Profitablity

Management Efficiency

Nuvation Bio has return on total asset (ROA) of (0.0965) % which means that it has lost $0.0965 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1203) %, meaning that it created substantial loss on money invested by shareholders. Nuvation Bio's management efficiency ratios could be used to measure how well Nuvation Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -0.13. In addition to that, Return On Capital Employed is expected to decline to -0.17. At present, Nuvation Bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 269.6 K, whereas Total Current Assets are forecasted to decline to about 417.4 M.

Technical Drivers

As of the 25th of April, Nuvation Bio secures the Downside Deviation of 4.62, mean deviation of 4.98, and Risk Adjusted Performance of 0.1009. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nuvation Bio, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Nuvation Bio, which can be compared to its peers in the industry. Please verify Nuvation Bio jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Nuvation Bio is priced some-what accurately, providing market reflects its recent price of 2.66 per share. Please also check out Nuvation Bio total risk alpha, which is currently at 0.0701 to check the company can sustain itself at a future point.

Nuvation Bio Price Movement Analysis

Nuvation Bio Insider Trading Activities

Nuvation Bio Predictive Daily Indicators

Nuvation Bio Corporate Filings

Nuvation Bio Forecast Models

Nuvation Bio's time-series forecasting models are one of many Nuvation Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nuvation Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nuvation Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nuvation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nuvation Bio. By using and applying Nuvation Stock analysis, traders can create a robust methodology for identifying Nuvation entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nuvation analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nuvation analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Nuvation Bio stock analysis indicators help investors evaluate how Nuvation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nuvation Bio shares will generate the highest return on investment. By understating and applying Nuvation Bio stock analysis, traders can identify Nuvation Bio position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.

Is Nuvation Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.